Fecal Microbial Transplant Via Nasogastric Tube for Active Pediatric Ulcerative Colitis
The DOI matches its Crossref record; 13 of the 14 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Ulcerative colitis (UC), a chronic inflammatory disease of the large intestine, is characterized by a dysregulated immune reaction. UC is associated with fecal dysbiosis. Human and animal studies support the fact that the gastrointestinal microbiome may trigger the intestinal immune response, resulting in UC. Fecal microbial transplantation (FMT), by changing the gastrointestinal microbiome of patients with UC, may be a therapeutic option. METHODS: Four patients with moderate symptoms defined by the Pediatric Ulcerative Colitis Activity Index were enrolled in a prospective, open-label study of FMT via nasogastric tube in pediatric UC (US Food and Drug Administration IND 14942). After the donor and patient evaluation, patients received FMT with follow-up evaluations at 2, 6, and 12 weeks after transplantation. Study subjects were maintained on their pretransplant medications. The Pediatric Ulcerative Colitis Activity Index score, C-reactive protein, and stool calprotectin were completed during each study visit. RESULTS: Four patients with UC were enrolled (all boys). Ages ranged from 13 to 16 years. Patients tolerated FMT without adverse effects. None of the patients clinically improved with FMT, nor were there any significant changes in stool calprotectin or laboratory values, including C-reactive protein, albumin, and hematocrit. Three individuals received additional standard medical therapies before the end of the study. CONCLUSIONS: This study, although showing that single-dose FMT via nasogastric tube is well tolerated in active pediatric UC, did not show any clinical or laboratory benefit.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These reports were followed by a number of small studies of FMT in children and adults with UC, CD, and pouchitis with mixed results.64–72”
From Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook (2015) · cites this paper as [66]
Citations
Cites
Levine, A., Griffiths, A., Markowitz, J., Wilson, D. C., Turner, D., Russell, R. K., Fell, J., Ruemmele, F. M., Walters, T., Sherlock, M., et al. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21493 · Cited by 1,512
Treating Clostridium difficile infection with fecal microbiota transplantation
Bakken, J. S., Borody, T., Brandt, L. J., Brill, J. V., Demarco, D. C., Franzos, M. A., Kelly, C., Khoruts, A., Louie, T., Martinelli, L. P., et al. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.08.014 · Cited by 1,003
(1958) · PubMed · Cited by 978
Youngster, I., Sauk, J., Pindar, C., Wilson, R. G., Kaplan, J. L., Smith, M. B., Alm, E. J., Gevers, D., Russell, G. H., & Hohmann, E. L. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu135 · Cited by 467 · cited 1×
“We did not evaluate whether single FMT by NG tube in our pediatric patients with UC caused engraftment of donor microbiota or changed recipient intestinal microbiota diversity, as has been described previously with single-donor NG tube delivery of FMT for patients with recurrent C difficile infection (9).”
BackgroundTreatment of Ulcerative Colitis Using Fecal Bacteriotherapy
Borody, T. J., Warren, E. F., Leis, S., Surace, R., & Ashman, O. (2003) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200307000-00012 · Cited by 388
PROSPECTIVE DIAGNOSIS OF SPINA BIFIDA
Brock, D. J. H., Scrimgeour, J. B., Chard, T., Leek, A. E., Kitau, M. J., & Leighton, P. C. (1975) · The Lancet · doi:10.1016/s0140-6736(75)91459-2 · Cited by 361
Phylogenetic Analysis of Dysbiosis in Ulcerative Colitis During Remission
Rajilić-Stojanović, M., Shanahan, F., Guarner, F., & de Vos, W. M. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e31827fec6d · Cited by 355
Angelberger, S., Reinisch, W., Makristathis, A., Lichtenberger, C., Dejaco, C., Papay, P., Novacek, G., Trauner, M., Loy, A., & Berry, D. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.257 · Cited by 330
Treatment of ulcerative colitis by implantation of normal colonic flora
Bennet, J., & Brinkman, M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91183-5 · Cited by 304
Beneficial modulation of the gut microbiota
Walsh, C. J., Guinane, C. M., O'Toole, P. W., & Cotter, P. D. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.03.035 · Cited by 274
Research works printed but not linked: 1
- Bauschlein M, 1997, Epilepsy, Kinderkrankenschwester, 16, 13
Cited by
Gut microbiota and IBD: causation or correlation?
Ni, J., Wu, G. D., Albenberg, L., & Tomov, V. T. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.88 · Cited by 1,778
European consensus conference on faecal microbiota transplantation in clinical practice
Cammarota, G., Ianiro, G., Tilg, H., Rajilić-Stojanović, M., Kump, P., Satokari, R., Sokol, H., Arkkila, P., Pintus, C., Hart, A., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-313017 · Cited by 1,207
Shen, Z.-H., Zhu, C.-X., Quan, Y.-S., Yang, Z.-Y., Wu, S., Luo, W.-W., Tan, B., & Wang, X.-Y. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i1.5 · Cited by 646
Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook
Kelly, C. R., Kahn, S., Kashyap, P., Laine, L., Rubin, D., Atreja, A., Moore, T., & Wu, G. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.008 · Cited by 572
Federici, S., Kredo-Russo, S., Valdés-Mas, R., Kviatcovsky, D., Weinstock, E., Matiuhin, Y., Silberberg, Y., Atarashi, K., Furuichi, M., Oka, A., et al. (2022) · Cell · doi:10.1016/j.cell.2022.07.003 · Cited by 542
Metadata
- Authors
- Suskind, D. L., Singh, N., Nielson, H., & Wahbeh, G.
- Affiliations
- Seattle Children's Hospital (US)
- Cedars-Sinai Medical Center (US)
- Corresponding author
- Suskind, David L.
- Nielson, Heather
- Wahbeh, Ghassan
- Venue
- Journal of Pediatric Gastroenterology and Nutrition
- Publisher
- Wiley
- Published
- 2015-01
- Volume
- 60
- Issue
- 1
- Pages
- 27-29
- ISSN
- 0277-2116 (ISSN-L)
- 1536-4801
- OpenAlex
- W2321645834
- Cited by
- 99
- References
- 14
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 4 · 2023: 4 · 2022: 6 · 2021: 8 · 2020: 11 · 2019: 11 · 2018: 16 · 2017: 14 · 2016: 13 · 2015: 8
- FWCI
- 7.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Pediatric Gastroenterology and Nutrition (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Microscopic Colitis
- Keywords
- fecal microbiota transplantation, pediatric ulcerative colitis, nasogastric tube administration, gut microbiota, calprotectin, C-reactive protein, tolerability, inflammatory bowel disease
- MeSH terms
- Adolescent, Anti-Inflammatory Agents, Non-Steroidal, Colitis, Ulcerative, Combined Modality Therapy, Feces, Follow-Up Studies, Hospitals, Pediatric, Humans, Immunosuppressive Agents, Intubation, Gastrointestinal, Male, Outpatient Clinics, Hospital, Severity of Illness Index, Washington, Probiotics, Therapies, Investigational, Donor Selection, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fecal Microbial Transplant Via Nasogastric Tube for Active Pediatric Ulcerative Colitis. https://app.cochat.ai/papers/10.1097/mpg.0000000000000544
- The paper
- Suskind, D. L., Singh, N., Nielson, H., & Wahbeh, G. (2015). Fecal Microbial Transplant Via Nasogastric Tube for Active Pediatric Ulcerative Colitis. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1097/mpg.0000000000000544
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.